bioAffinity Technologies (BIAFW) Gains from Sales and Divestitures (2022 - 2026)
bioAffinity Technologies (BIAFW) reported Gains from Sales and Divestitures of $512.0 for Q1 2026, down 99.45% year-over-year from $92601.0 in Q1 2025, and down 92.88% quarter-over-quarter from $7195.0 in Q4 2025.
bioAffinity Technologies (BIAFW) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 5 years of Gains from Sales and Divestitures data on file, last reported at $512.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $512.0, down 99.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $512.0 (down 99.45% YoY), and the FY2025 annual result was $7195.0, down 5.59% from the prior year.
- Gains from Sales and Divestitures declined to $512.0 in Q1 2026 per BIAFW's latest filing, from $7195.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $172660.0 in Q2 2025 and troughed at $106.0 in Q3 2024.
- A 5-year average of $35698.5 and a median of $7621.0 in 2024 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2025 and 2026: Gains from Sales and Divestitures jumped 5209.43% in 2025, then plunged 99.45% in 2026.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $29728.0 in 2022, then soared by 98.64% to $59051.0 in 2023, then sank by 87.09% to $7621.0 in 2024, then retreated by 5.59% to $7195.0 in 2025, then plunged by 92.88% to $512.0 in 2026.
- Business Quant data shows BIAFW's Gains from Sales and Divestitures at $512.0 in Q1 2026, $7195.0 in Q4 2025, and $5628.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 512.00 |
| Mar 31, 2026 | 512.00 |
| Dec 31, 2025 | 7,195.00 |
| Dec 31, 2025 | 7,195.00 |
| Sep 30, 2025 | 5,628.00 |
| Sep 30, 2025 | 5,628.00 |
| Jun 30, 2025 | 172,660.00 |
| Jun 30, 2025 | 172,660.00 |
| Mar 31, 2025 | 92,601.00 |
| Mar 31, 2025 | 92,601.00 |
| Dec 31, 2024 | 7,621.00 |
| Dec 31, 2024 | 7,621.00 |
| Sep 30, 2024 | 106.00 |
| Sep 30, 2024 | 106.00 |
| Jun 30, 2024 | 6,846.00 |
| Jun 30, 2024 | 6,846.00 |
| Mar 31, 2024 | 10,736.00 |
| Mar 31, 2024 | 10,736.00 |
| Dec 31, 2023 | 59,051.00 |
| Dec 31, 2023 | 59,051.00 |